#USA #Chelmsford #VPT Rad #Foss Therapy #HDR Testing

VPT Rad Expands Its Cutting-Edge Capabilities with the Launch of Foss Therapy Model 812

VPT Rad, an esteemed sister company of VPT, Inc., has recently made headlines with the introduction of the Foss Therapy Model 812, a significant advancement in high-dose-rate (HDR) testing capabilities. Known for providing comprehensive radiation testing services, VPT Rad’s new model is set to greatly enhance its offerings, particularly for clients in the aerospace, defense, commercial, and healthcare sectors, where precision and reliability in radiation testing are paramount.

Significant Advancements in HDR Testing

The Foss Therapy Model 812 comes equipped with impressive technological specifications. Featuring three source tubes, each capable of holding a maximum of 7,500 curies of Cobalt-60, the system can operate at a total of 22,500 curies. One of the most notable features is its remarkable dose rate, which can reach up to 2.4 Mrad per hour (23,500 Gy per hour), more than tripling the capabilities of VPT Rad's previous model, the GC220 irradiator. This significant increase will undoubtedly cater to a wider range of testing requirements and improve the efficiency of client projects.

A unique aspect of the Model 812 is its sample chamber size, measuring 8 inches by 12 inches, offering three times the volume compared to prior setups. This advancement enhances the ability to handle larger samples or packages for testing, streamlining operations in environments that require both speed and accuracy.

Versatility in Application

Customization is a key benefit of the Model 812, as the dose rate can easily be adjusted by activating various numbers of Cobalt-60 tubes. This flexibility ensures that VPT Rad can meet diverse payload sizes and dose rate requirements, accommodating different project specifications efficiently.

Particularly noteworthy is the model's swift gamma sterilization capabilities, which facilitate rapid turnaround times for sample processing. The chamber’s increased size allows for larger samples, making the system highly beneficial for sterilization, especially in the medical field where time and precision are crucial.

Additionally, VPT Rad has integrated a rotating turntable that spins at 12 RPM within the chamber. This innovative feature guarantees uniform radiation exposure across samples, minimizing variations and uncertainties. Coupled with NIST traceable alanine pellets currently in use, the accuracy and reliability of the testing process are significantly enhanced.

Strong Commitment to Regulatory Standards

Aridio Sanchez, President of VPT Rad, emphasized the importance of the Foss Therapy Model 812 in meeting stringent industry standards. “The introduction of the 812 model marks a substantial increase in our HDR facility's capacity for MIL-STD-883 qualifications, with attenuation capabilities up to 300 rad/s (Si),” Sanchez noted. He also addressed a critical gap in the sterilization community, stating, “Our service can now achieve a sterilization dose in less than two hours, a critical improvement in operational efficiency.”

Furthermore, VPT Rad is also optimizing its existing JLS 81-22 room irradiator, which will enhance its ELDRS chamber’s dose rate, increasing efficiency in long exposure projects significantly. Although the increase in dose rate might appear minimal, it equates to a 30% improvement in overall exposure time, translating to a reduction from approximately 164 days to just 114 days for a 100Krad ELDRS exposure. Thus, providing clients with shorter lead times is a primary focus for VPT Rad moving forward.

About VPT Rad

VPT Radiation Laboratory and Test Services operates from an advanced facility located roughly 20 miles north of Boston in Chelmsford, Massachusetts. The organization specializes in creating suitable environments and delivering test solutions specifically for evaluating electronic devices used in sectors susceptible to ionizing radiation, such as aerospace and nuclear applications. Furthermore, the newly launched website will provide enhanced access to service details and technical resources, illustrating VPT Rad’s dedication to customer support and transparency in their operations.

In conclusion, the launch of the Foss Therapy Model 812 marks a pivotal moment in the evolution of VPT Rad’s testing capabilities. With its state-of-the-art features and ongoing commitment to innovation, VPT Rad is poised to lead advancements in HDR testing solutions, ensuring the safety and longevity of critical electronic components across numerous industries.